Celsense is Issued Patent for MRI Cell Tracking Product
Cell Sense patent added to a growing intellectual property portfolio in cellular and molecular imaging tools Pittsburgh, PA (PRWEB) December 22, 2011 Celsense, Inc., announced today that it has received a Notice of Allowance for US Patent Application 10/586,015 with claims covering its MRI cell tracking product, Cell Sense. Cell Sense is a perfluorocarbon tracer agent used to label cells ex vivo, making them detectable in vivo after transplantation using magnetic resonance imaging (“MRI”). Invented by Eric Ahrens at Carnegie Mellon University, Cell Sense can be used to non-invasively i
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 313
- Bankruptcy 44
- Business 135
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 58
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4